Sarasota Arthritis Resear is categorized under Primary Care Centers in Sarasota, FL and active since 2009.
Sarasota Arthritis Resear was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ronald I Weitzner at the company’s single location by writing to 1945 Versailles St # 101, Sarasota, Florida FL 34239 or by phoning (941) 366-1244. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Sarasota Arthritis Resear |
Contact Person: | Ronald I Weitzner |
Address: | 1945 Versailles St # 101, Sarasota, Florida 34239 |
Phone Number: | (941) 366-1244 |
Website Address: | arthritiscenters.net |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Primary Care Centers |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Sarasota Arthritis Resear was started in 2009 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ronald I Weitzner for inquiries that concern Sarasota Arthritis Resear by calling the company number (941) 366-1244, as your correspondence is most welcome. Additionally, the physical location of the single location of Sarasota Arthritis Resear can be found at the coordinates 27.300707,-82.532535 as well as the street address 1945 Versailles St # 101 in Sarasota, Florida 34239.
For its online presence, you may visit Sarasota Arthritis Resear’s website at arthritiscenters.net and engage with its social media outlets through on Twitter and on Facebook.